Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications
M Palomo, AB Moreno-Castaño, MQ Salas… - Frontiers in …, 2023 - frontiersin.org
The endothelium is a biologically active interface with multiple functions, some of them
common throughout the vascular tree, and others that depend on its anatomical location …
common throughout the vascular tree, and others that depend on its anatomical location …
Ambulatory models for autologous stem-cell transplantation: a systematic review of the health impact
MÁ Prieto del Prado, F Fernández Avilés - Frontiers in immunology, 2024 - frontiersin.org
Autologous stem-cell transplantation (ASCT) is the standard of care for the management of
multiple myeloma and has a well-established role in the treatment of some types of …
multiple myeloma and has a well-established role in the treatment of some types of …
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of …
S Escribano-Serrat, A Pedraza… - Bone Marrow …, 2024 - nature.com
Since 2021 the use of G-CSF was implemented in allo-HCT with PTCY-based prophylaxis
with the aim of shortening the aplastic phase and reducing infectious complications. This …
with the aim of shortening the aplastic phase and reducing infectious complications. This …
[HTML][HTML] Feasibility of a hospital-at-home program for autologous hematopoietic stem cell transplantation
S González-Barrera, G Martín-Sánchez… - … and Cellular Therapy, 2023 - Elsevier
ABSTRACT The Hospital at Home (HaH) model has been positioned as an appropriate
therapeutic strategy for selected patients undergoing autologous hematopoietic stem cell …
therapeutic strategy for selected patients undergoing autologous hematopoietic stem cell …
An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous HCT
AB Moreno-Castaño, M Palomo… - Bone Marrow …, 2022 - nature.com
Engraftment syndrome (ES) is a common complication after autologous hematopoietic cell
transplantation (auto-HCT) whose pathophysiological substrate remains unclear. We …
transplantation (auto-HCT) whose pathophysiological substrate remains unclear. We …
[HTML][HTML] At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens
A Martínez-Roca, C Jiménez-Vicente, B Merchán… - Cancers, 2024 - mdpi.com
Background: Even though venetoclax in combination with azacitidine (VenAza) is
considered a low-intensity regimen, its patients present a high incidence of cytopenia and …
considered a low-intensity regimen, its patients present a high incidence of cytopenia and …
[HTML][HTML] A prospective, randomized trial examining the use of G-CSF versus no G-CSF in patients post-autologous transplantation
D Grosso, B Leiby, L Wilde, M Carabasi… - … and Cellular Therapy, 2022 - Elsevier
Contemporary, prospective data regarding the impact of granulocyte-colony stimulating
factor (G-CSF) on outcomes after autologous hematopoietic stem cell transplantation (Auto …
factor (G-CSF) on outcomes after autologous hematopoietic stem cell transplantation (Auto …
[HTML][HTML] Personalized at-home autologous hematopoietic stem cell transplantation during the SARS-CoV-2 outbreak
A Martínez-Roca, LG Rodríguez-Lobato… - Leukemia …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reached Spain
presumably in February 2020. On March 13th, the Spanish government ordered a national …
presumably in February 2020. On March 13th, the Spanish government ordered a national …
[PDF][PDF] At-home HSCT
F Fernandez-Avilés… - The EBMT Handbook …, 2018 - library.oapen.org
Toxicity and mortality associated with auto-HSCT have been reduced, and outpatient
parenteral antimicrobial treatment has been proven feasible and safe, thanks to modern …
parenteral antimicrobial treatment has been proven feasible and safe, thanks to modern …
Procalcitonin and C-Reactive Protein/Procalcitonin Ratio for Distinguishing between Infectious and Neoplastic Fever in Cancer Patients.
L Fan, X Ding - Alternative Therapies in Health & Medicine, 2023 - search.ebscohost.com
Objective• This study aims to investigate the potential of procalcitonin (PCT) levels and the C-
reactive protein/procalcitonin (CRP/PCT) ratio as markers for distinguishing between …
reactive protein/procalcitonin (CRP/PCT) ratio as markers for distinguishing between …